Provided by Tiger Trade Technology Pte. Ltd.

Credit Suisse Holdings

2,499.08
+0.17900.01%
Number of Gainers:56
Number of Losers:40
Number of Flat:1
PE:- -
High:2,506.76
Open:2,498.91
Low:2,494.81
Close:2,498.90
Volume:974.33M
Turnover:196.25B
Market Cap:52.34T
Float Cap:48.97T

Loading ...

United Parcel Service Likely to Deliver In-Line Results, UBS Says

MT Newswires Live
·
Oct 02

Google Cloud: Announces General Availability of Spanner Queues for Transactional Messaging in AI Agent Workloads - Blog

THOMSON REUTERS
·
Oct 02

Nvidia Stock (NVDA) Hits All-Time High Days After Announcing Record Buyback

TIPRANKS
·
Oct 02

McDonald’s Stock (MCD) Looks Like a Buy after the Dip

TIPRANKS
·
Oct 02

Nike's Right-Sizing Efforts are Dragging

Dow Jones
·
Oct 02

Amazon and Microsoft Cloud Businesses Could Face Tougher EU Rules as Soon as November

TIPRANKS
·
Oct 02

Perspective Therapeutics [212Pb]VMT01 Melanoma Trial Data Set for SITC 2026 Presentation

Reuters
·
Oct 02

Update: BofA Securities Adjusts Nike Price Target to $24 From $30, Maintains Underperform Rating

MT Newswires Live
·
Oct 02

NVIDIA Launches 64GB DGX Spark With Halved Memory Starting at $4,999, While 128GB Version Jumps to $6,950

Deep News
·
Oct 02

Market Chatter: UBS Engages With Nordea Bank Over Potential Switzerland Exit

MT Newswires Live
·
Oct 02

US-Listed ETFs on Course for Record Annual Inflows, State Street Says

Reuters
·
Oct 02

Can Google's New Flagship Model Finally Match OpenAI and Anthropic at the Frontier?

Deep News
·
Oct 02

hy Nvidia and Broadcom Stocks Are Climbing Today — and How Far Wall Street Sees Them Going

TIPRANKS
·
Oct 02

Nike's Downward EPS Revisions Could Continue, UBS Says

MT Newswires Live
·
Oct 02

Verizon is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
Oct 02

Pfizer Says Phase 3 Trials Show Litfulo Improves Repigmentation in Nonsegmental Vitiligo Patients at Week 52

Reuters
·
Oct 02

Texas Instruments Inc Stock (TXN) Moved Up by 4.43% on Oct 2: Key Drivers Unveiled

TradingKey
·
Oct 02

Pfizer - to Submit Litfulo Phase 3 Data to FDA and Ema

THOMSON REUTERS
·
Oct 02

Pfizer - Litfulo Safety Profile in Nsv Consistent with Alopecia Areata; no New Safety Signals

THOMSON REUTERS
·
Oct 02

Pfizer’s Litfulo Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo~

THOMSON REUTERS
·
Oct 02